[Mediastinal lymphomas]

S Rauthe1,2, A Rosenwald3,4

  • 1Institut für Pathologie, Universität Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Deutschland.

Der Pathologe
|August 11, 2016
PubMed

Insights

Mediastinal lymphomas, including classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma, present diagnostic challenges. Accurate identification is crucial for appropriate treatment and prognosis, especially for mediastinal grey zone lymphomas.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Mediastinal lymphomas pose diagnostic and clinical challenges, often presenting as emergencies with small biopsy samples.
  • Classical Hodgkin's lymphoma (CHL), predominantly the nodular sclerosis subtype, is the most common mediastinal lymphoma.
  • Distinguishing CHL from primary mediastinal large B-cell lymphoma (PMBCL) is critical due to different treatment strategies.

Purpose of the Study:

  • To highlight the diagnostic difficulties in mediastinal lymphomas, particularly differentiating CHL from PMBCL.
  • To emphasize the importance of recognizing mediastinal grey zone lymphomas (MGZL) with intermediate features.
  • To discuss rare mediastinal lymphomas like extranodal thymic marginal zone lymphomas (MALT type) and T-lymphoblastic lymphomas.

Main Methods:

  • Morphological assessment of small biopsy samples.
  • Immunohistochemical analysis to identify cell phenotypes (e.g., CD20, CD79a, CD30).
  • Differential diagnosis including thymomas and thymic hyperplasia for T-lymphoblastic lymphomas.

Main Results:

  • Morphological and immunohistochemical detection of Hodgkin and Reed-Sternberg cells can be challenging in sclerotic CHL.
  • PMBCL exhibits sheets of blast cells with a strong B-cell phenotype (CD20+, CD79a+), often CD30+.
  • MGZL shows intermediate features between CHL and PMBCL, associated with a slightly poorer prognosis.

Conclusions:

  • Accurate diagnosis of mediastinal lymphomas, including CHL, PMBCL, and MGZL, is essential for guiding therapy.
  • Immunohistochemistry is vital for characterizing cell phenotypes and distinguishing between these lymphoma subtypes.
  • Rare mediastinal lymphomas and T-lymphoblastic lymphomas require careful differential diagnosis to ensure appropriate management.